Unethical use of placebo controls

descriptionPublicationkeyboard_double_arrow_right Article 01 Dec 2002 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 181, pages 532-533 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )Publicly funded

Authors: A. K. Jainer; N. Soni;

doi: 10.1192/bjp.181.6.532-a

Unethical use of placebo controls

- Summary
- Metrics

Abstract

Klysner et al ([2002][1]) evaluated the prophylactic efficacy of citalopram in comparison with placebo in elderly patients, and stated ‘the highly recurrent nature of major depression in the young and the elderly warrants long-term antidepressant treatment’. In view of this, is it ethical to use

Related Organizations

St Michael's Hospital
United Kingdom

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average